About: http://webisa.webdatacommons.org/117011944

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The startup, named Sitari Pharmaceuticals, is targeting the transglutaminase 2 (TG2) pathway as it develops drugs for celiac and other diseases.
http://www.w3.org/ns/prov#wasQuotedFrom	genengnews.com